⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
prnewswire.com
LLY
AI in Drug Discovery Market worth $17.56 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
NVDA
LLY
GOOG
MSFT
ILMN
Jeffrey Hayzlett, C-SUITE NETWORK™, Emovid™, and Didit Launch "Voices of 250" Initiative to Mobilize America's Business Leaders for the Nation's 250th Anniversary
prnewswire.com
NOC
LLY
NDAQ
Leading Healthcare Organizations Launch Initiative to Help Families Get Earlier Answers
prnewswire.com
LLY
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
prnewswire.com
HELP
ATAI
JNJ
CMPS
LLY
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
globenewswire.com
NVO
LLY
Virginia's Advanced Pharmaceutical Manufacturing Tech Hub Secures Federal Investment to Launch End-to-End Commercialization Project
prnewswire.com
AZN
LLY
MRK
Altus Dental Helps Advance Oral Health Innovation Through MassChallenge Healthcare Challenge Program
prnewswire.com
LLY
From Polyclonal to Monoclonal Antibodies: Cloud-Clone Builds a Global Benchmark for Diverse Research Antibodies via Full In-House R&D
accessnewswire.com
PFE
LLY
Neo Launches with $100M to Secure AI Software Across the Enterprise
globenewswire.com
S
PANW
SHOP
NVDA
MSFT
GOOG
AMZN
CRM
ADBE
IBM
INTC
AMD
QCOM
META
TWLO
LI
CVNA
DDOG
CRWD
OKTA
PLTR
SNOW
SMCI
MU
AMAT
LRCX
ASML
ORCL
SAP
CSCO
FTNT
CHKP
VRTX
REGN
GILD
BIIB
AZN
PFE
MRNA
BMY
AMGN
LLY
ABBV
NVO
SNPS
CDNS
MCHP
NXPI
ON
ADI
TXN
CRSP
EXAS
ALGN
TDOC
ROKU
COIN
PYPL
HOOD